Literature DB >> 20798437

Grafting with hydroxyapatite granules for defects of acetabular bone at revision total hip replacement: a minimum ten-year follow-up.

T Sakai1, K Ohzono, T Nishii, H Miki, M Takao, N Sugano.   

Abstract

The long-term results of grafting with hydroxyapatite granules for acetabular deficiency in revision total hip replacement are not well known. We have evaluated the results of revision using a modular cup with hydroxyapatite grafting for Paprosky type 2 and 3 acetabular defects at a minimum of ten years' follow-up. We retrospectively reviewed 49 acetabular revisions at a mean of 135 months (120 to 178). There was one type 2B, ten 2C, 28 3A and ten 3B hips. With loosening as the endpoint, the survival rate was 74.2% (95% confidence interval 58.3 to 90.1). Radiologically, four of the type 3A hips (14%) and six of the type 3B hips (60%) showed aseptic loosening with collapse of the hydroxyapatite layer, whereas no loosening occurred in type 2 hips. There was consolidation of the hydroxyapatite layer in 33 hips (66%). Loosening was detected in nine of 29 hips (31%) without cement and in one of 20 hips (5%) with cement (p = 0.03, Fisher's exact probability test). The linear wear and annual wear rate did not correlate with loosening. These results suggest that the long-term results of hydroxyapatite grafting with cement for type 2 and 3A hips are encouraging.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20798437     DOI: 10.1302/0301-620X.92B9.24555

Source DB:  PubMed          Journal:  J Bone Joint Surg Br        ISSN: 0301-620X


  2 in total

1.  Modular acetabular reconstructive cup in acetabular revision total hip arthroplasty at a minimum ten year follow-up.

Authors:  Takashi Sakai; Kenji Ohzono; Takashi Nishii; Masaki Takao; Hidenobu Miki; Nobuo Nakamura; Nobuhiko Sugano
Journal:  Int Orthop       Date:  2013-02-20       Impact factor: 3.075

2.  Acetabular reconstruction using a free fibular autograft in total hip arthroplasty revisions.

Authors:  Thibaut Noailles; Chiaki Tanaka; Francois Lintz; Sylvie Collon; Kevin Bargoin; Francois Gouin
Journal:  Int Orthop       Date:  2014-07-20       Impact factor: 3.075

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.